dr. wolchock on phase iii checkmate-067 findings
Published 9 years ago • 307 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
2:31
dr. wolchok on updated checkmate-067 results for melanoma
-
1:33
dr. wolchok on the safety profile in checkmate-067 in melanoma
-
2:05
dr. shoushtari on the design of the checkmate-067 trial in advanced melanoma
-
3:47
checkmate 067: a phase iii trial of nivolumab combined with ipilimumab
-
1:26
metastatic melanoma: the checkmate 067 and 069 trials
-
0:59
checkmate 067: phase 3 trial of nivolumab in melanoma
-
3:05
phase 3 checkmate 067 trial of nivolumab in previously untreated advanced melanoma
-
1:42
dr. agarwala on the significance of os and toxicity results in checkmate-067
-
13:16
the immune system vs. cancer | jedd wolchok | tedxtimessquare
-
56:47
outcome measures in chm clinical trials
-
45:42
what you need to know: diagnosing melanoma
-
1:44
dr. jedd wolchok talks about a recent trial and its effects on untreated melanoma patients
-
1:38
dr. wolchok on next steps for patients with melanoma who fail on pd-1 monotherapy
-
3:45
update on checkmate 067, an advanced melanoma clinical trial
-
0:47
dr. wolchok on weighing risk and benefit of nivolumab/ipilimumab combo in melanoma
-
2:53
10-year insights from keynote 006 and checkmate 067 trials in melanoma
-
1:38
patients in checkmate 067 demonstrate durable complete responses
-
2:45
dr. wolchok on ipilimumab after complete resection of stage iii melanoma
-
6:35
phase iii study finds initial nivolumab-based treatment halts melanoma progression
-
0:57
dr. postow on os results of checkmate-069 study
-
1:56
checkmate 067: combined nivolumab and ipilimumab or monotherapy in untreated melanoma
-
2:18
dr. jeffrey weber on checkmate-064 trial for advanced melanoma